100. Disruptive forces in biotech, Jake Becraft, Lex Rovner, Josh Mandel-Brehm, & Nabiha Saklayen
Jake Becraft is co-founder and CEO of Strand Therapeutics, an emerging biotechnology company at the forefront of mRNA therapeutics. With colleagues at MIT’s Synthetic Biology Center, he led the develo...
27 Huhti 20221h 5min
99. Precision medicine for sepsis, Tim Sweeney, Co-Founder and CEO, Inflammatix, Inc.
Tim Sweeney, MD, PhD, is co-founder and CEO of Inflammatix. Tim has extensive experience in medical practice (general & trauma surgery), bench research, and bioinformatics / machine learning. While tr...
20 Huhti 202219min
98. Brain health disorders, Al Robichaud, Ph.D., CSO, Sage Therapeutics
Al leads teams in early-stage discovery up through non-clinical development, identifying new drug candidates for advancement into clinical research. Al joined Sage as CSO in 2011, with more than 20 ye...
13 Huhti 202218min
97. Patient driven treatments in rare diseases, Stuart Peltz, Founder & CEO, PTC Therapeutics
Dr. Stuart Peltz founded PTC Therapeutics in 1998 and has served as Chief Executive Officer and a member of the Board of Directors since the company’s inception. Under his leadership, PTC has grown ...
6 Huhti 202228min
96. Obesity & rare disease, Patrick Kleyn, SVP and Head of Translational R&D,Rhythm Pharmaceuticals
Patrick Kleyn joined Rhythm in 2018 with over 25 years’ experience in human genetics and genomics, and he was named as head of TRAD in 2021. Prior to joining Rhythm, Patrick has held leadership roles ...
30 Maalis 202220min
95. Gene writing, Dr. Jake Rubens, Co-Founder & CIO, Hari Pujar, COO, Tessera Therapeutics
Jacob(Jake)Rubens, Co-Founder, Chief Innovation Officer Jake is Co-Founder and Chief Innovation Officer of Tessera Therapeutics, as well as a Principal at Flagship Pioneering. Jake joined Flagship Pi...
23 Maalis 202225min
94. Cell therapy in a war on cancer, Kleanthis Xanthopoulos, Co-Founder & CEO, Shoreline Biosciences
Kleanthis is a serial biotechnology entrepreneur with over two decades of experience in the biotechnology and pharmaceutical research industries as an executive, company founder, chief executive offic...
16 Maalis 202225min
93. Human-centric data and AI for improved drug development, David Berry, Founder & CEO, Valo Health
David Berry is the Founder and CEO of Valo and since 2005, has served as General Partner at Flagship Pioneering, having founded over 25 companies including Indigo Agriculture, Seres Therapeutics (NASD...
9 Maalis 202233min
